Quantum Biopharma Ltd. Files August 2025 6-K Report
Ticker: QNTM · Form: 6-K · Filed: Aug 21, 2025 · CIK: 1771885
| Field | Detail |
|---|---|
| Company | Quantum Biopharma Ltd. (QNTM) |
| Form Type | 6-K |
| Filed Date | Aug 21, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-k, company-update
TL;DR
Quantum Biopharma (fka FSD Pharma) filed their August 6-K, sticking with the 20-F annual report format.
AI Summary
Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on August 21, 2025. The company, incorporated in A6 and headquartered in Toronto, Canada, is in the Pharmaceutical Preparations industry. This filing is for the month of August 2025 and indicates the company will file its annual reports under Form 20-F.
Why It Matters
This filing provides an update on Quantum Biopharma's reporting status and confirms their adherence to SEC regulations for foreign private issuers, which is crucial for investor transparency.
Risk Assessment
Risk Level: low — This is a routine administrative filing (Form 6-K) confirming reporting status and not disclosing new material financial or operational information.
Key Players & Entities
- Quantum Biopharma Ltd. (company) — Filer of the report
- FSD Pharma Inc. (company) — Former name of the registrant
- August 2025 (date) — Reporting period for the Form 6-K
- 20250821 (date) — Filing date
- Toronto, Canada (location) — Company headquarters
- Form 20-F (document) — Annual report form to be filed
- Form 6-K (document) — Type of filing
FAQ
What is the primary business of Quantum Biopharma Ltd.?
Quantum Biopharma Ltd. is in the Pharmaceutical Preparations industry, with SIC code 2834.
When was Quantum Biopharma Ltd. formerly known as?
Quantum Biopharma Ltd. was formerly known as FSD Pharma Inc., with a name change date of March 27, 2019.
What is the principal executive office address of Quantum Biopharma Ltd.?
The principal executive office is located at 55 University Ave., Suite 1003, Toronto, Ontario M5J2H7, Canada.
Which form will Quantum Biopharma Ltd. use for its annual reports?
Quantum Biopharma Ltd. indicates it will file its annual reports under cover of Form 20-F.
What is the filing date and reporting period for this Form 6-K?
This Form 6-K was filed on August 21, 2025, and is for the month of August 2025.
Filing Stats: 151 words · 1 min read · ~1 pages · Grade level 11.2 · Accepted 2025-08-21 07:00:04
Filing Documents
- f6k_082125.htm (6-K) — 6KB
- exh_991.htm (EX-99.1) — 7KB
- 0001171843-25-005531.txt ( ) — 14KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Quantum BioPharma Ltd. (Registrant) Date: August 21, 2025 /s/ Donal Carroll Donal Carroll Chief Financial Officer EXHIBIT INDEX Exhibit Number Description 99.1 Press Release dated August 21, 2025